Product image of Migraitan (Sumatriptan) supplied by GNH India

Migraitan

Active Ingredient:
Sumatriptan
Origin:
EU

Migraitan (Sumatriptan)

Sumatriptan, the active ingredient in Migraitan, is a 5‑HT1B/1D receptor agonist presented as an oral tablet for oral use. It is indicated for the acute treatment of migraine attacks in adults and works by reversing the vascular and neurogenic changes that underlie migraine pain.

GNH India supplies Migraitan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for healthcare providers across multiple regions, including Europe, Asia and Africa.

Manufacturer / TM Owner

Bristol Laboratories Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Sumatriptan belongs to the triptan class and is used for acute migraine management.

  • Migraine attack: aborts an ongoing migraine episode, relieving headache and associated symptoms.
  • Migraine with aura: provides rapid relief of headache and visual disturbances when taken at onset.
  • Cluster headache: can be used to treat acute attacks of cluster headache in adults.

How It Works

  • Sumatriptan acts as an agonist at serotonin 5‑HT1B and 5‑HT1D receptors located on cranial blood vessels and trigeminal nerve endings. Activation of these receptors causes vasoconstriction of dilated intracranial vessels and inhibits the release of pro‑inflammatory neuropeptides, thereby terminating the migraine cascade.

Side Effects

Common Side Effects

  • Chest discomfort: mild pressure or tightness in the chest.
  • Tingling or numbness: sensation of pins and needles, often in the face or extremities.
  • Nausea: upset stomach or urge to vomit.
  • Dizziness: feeling light‑headed or unsteady.
  • Dry mouth: reduced salivation.
  • Fatigue: unusual tiredness or lack of energy.

Serious or Rare Side Effects

  • Coronary vasospasm: sudden narrowing of coronary arteries that can cause chest pain.
  • Serotonin syndrome: potentially life‑threatening condition when combined with other serotonergic agents.
  • Severe allergic reaction: rash, swelling, or difficulty breathing.
  • Hypertension: significant increase in blood pressure.
  • Myocardial infarction: heart attack in susceptible individuals.
  • Severe skin reactions: such as Stevens‑Johnson syndrome.

Precautions & Warnings

Before using Sumatriptan, consider the following precautions:

  • Cardiovascular assessment: avoid in patients with uncontrolled coronary artery disease or recent myocardial infarction.
  • Serotonergic drugs: caution when combined with SSRIs, SNRIs, or MAO inhibitors due to risk of serotonin syndrome.
  • Pregnancy: use only if the potential benefit justifies the potential risk to the fetus.
  • Renal or hepatic impairment: dose adjustment may be required; monitor liver and kidney function.
  • Age restrictions: not recommended for children under 12 years of age.
  • Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Sumatriptan may interact with several drug classes. Review the following interactions before prescribing.

Major Interactions (Avoid)

  • MAO inhibitors: concurrent use can precipitate severe hypertension.
  • Ergotamine derivatives: combined vasoconstrictive effects increase risk of coronary spasm.
  • Other triptans: additive vasoconstriction may lead to cardiovascular events.
  • Monoamine oxidase inhibitors: heightened risk of serotonin syndrome.
  • Certain antihypertensives: may potentiate blood pressure changes.

Moderate Interactions (Monitor Closely)

  • SSRIs and SNRIs: monitor for signs of serotonin syndrome.
  • CYP3A4 inhibitors (e.g., ketoconazole): may increase sumatriptan plasma levels.
  • Antihistamines: can enhance dizziness or sedation.
  • Oral contraceptives: may affect metabolism, requiring observation.

Frequently Asked Questions

Migraitan contains sumatriptan, which is prescribed for the acute treatment of migraine attacks in adults. It helps to relieve headache pain and associated symptoms such as nausea, photophobia, and phonophobia when taken at the onset of a migraine.

Sumatriptan works by stimulating serotonin 5‑HT1B and 5‑HT1D receptors on cranial blood vessels and trigeminal nerve endings. This causes the vessels to constrict and blocks the release of inflammatory neuropeptides, interrupting the migraine cascade.

The appropriate dose of Migraitan is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and any concomitant medications. Patients should follow the prescriber’s instructions exactly.

Safety of sumatriptan in pregnancy or while breastfeeding has not been fully established. It should only be used if the potential benefit outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified clinician.

To request Migraitan, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Migraitan (sumatriptan) belongs to the triptan class, which is specifically designed for rapid relief of migraine attacks. Compared with non‑specific analgesics, triptans target serotonin receptors to address both vascular and neurogenic components of migraine, often providing faster and more complete symptom resolution.

Migraitan should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Migraitan is taken orally, usually as a tablet, at the first sign of a migraine attack. The tablet should be swallowed whole with water and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious risks include coronary vasospasm, myocardial infarction, and serotonin syndrome, especially when used with other serotonergic drugs. Patients with cardiovascular disease, uncontrolled hypertension, or those taking MAO inhibitors should avoid Migraitan or use it only under close medical supervision.

Migraitan is contraindicated in individuals with known hypersensitivity to sumatriptan, uncontrolled coronary artery disease, recent myocardial infarction, severe hypertension, or those currently using ergotamine-containing medications or monoamine oxidase inhibitors.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Sumatriptan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT